Cirugía De La Mama

Total Page:16

File Type:pdf, Size:1020Kb

Cirugía De La Mama 25,5 mm 15 GUÍAS CLÍNICAS DE LA ASOCIACIÓN ESPAÑOLA DE CIRUJANOS 15 CIRUGÍA DE LA MAMA Fernando Domínguez Cunchillos Sapiña Juan Blas Ballester Parga Gonzalo de Castro Fernando Domínguez Cunchillos Juan Blas Ballester Sapiña Gonzalo de Castro Parga CIRUGÍA DE LA MAMA CIRUGÍA SECCIÓN DE PATOLOGÍA DE LA MAMA Portada AEC Cirugia de la mama.indd 1 17/10/17 17:47 Guías Clínicas de la Asociación Española de Cirujanos CIRUGÍA DE LA MAMA EDITORES Fernando Domínguez Cunchillos Juan Blas Ballester Sapiña Gonzalo de Castro Parga SECCIÓN DE PATOLOGÍA DE LA MAMA © Copyright 2017. Fernando Domínguez Cunchillos, Juan Blas Ballester Sapiña, Gonzalo de Castro Parga. © Copyright 2017. Asociación Española de Cirujanos. © Copyright 2017. Arán Ediciones, S.L. Castelló, 128, 1.º - 28006 Madrid e-mail: [email protected] http://www.grupoaran.com Reservados todos los derechos. Esta publicación no puede ser reproducida o transmitida, total o parcialmente, por cualquier medio, electrónico o mecánico, ni por fotocopia, grabación u otro sistema de reproducción de información sin el permiso por escrito de los titulares del Copyright. El contenido de este libro es responsabilidad exclusiva de los autores. La Editorial declina toda responsabilidad sobre el mismo. ISBN 1.ª Edición: 978-84-95913-97-5 ISBN 2.ª Edición: 978-84-17046-18-7 Depósito Legal: M-27661-2017 Impreso en España Printed in Spain CIRUGÍA DE LA MAMA EDITORES F. Domínguez Cunchillos J. B. Ballester Sapiña G. de Castro Parga AUTORES A. Abascal Amo M. Fraile Vasallo B. Acea Nebril G. Freiría Barreiro J. Aguilar Jiménez C. A. Fuster Diana L. Alfaro Galán P. Garaulet González A. Alonso Amigo R. García Berrio L. Apesteguía Ciriza A. García-Vilanova Comas F. M. Armas Serrano A. García Novoa P. Armendáriz Rubio E. García Olivares C. Artieda Soto A. García Villanueva J. B. Ballester Sapiña J. Á. Garijo Álvarez T. Balsa Marín M.ª Á. Gil Olarte R. Barriga Sánchez J. Gómez Ramírez E. Buch Villa P. J. González Noguera C. Bueno Muiño M. González Pérez R. Calpena Rico I. Gutiérrez Giner P. Cansado Martínez J. R. Hernández Hernández F. Carabantes Ocón J. J. Illarramendi Mañas F. J. Cardenal Murillo C. Jiménez Mazure G. de Castro Parga M. J. Lamas González M.ª V. Collado Guirao P. C. Lara Jiménez L. Comín Novella I. Larrañaga Blanc A. Corominas Cishek D. Legupin Tubío M. Á. Corral Sánchez J. M. de León Carrillo S. de la Cruz Sánchez R. León Ledesma C. Díaz Carballada M. Lloret Sáez-Bravo M. Díaz-Miguel Maseda M. Á. Lorenzo Campos J. Díez Izquierdo M. Á. Lorenzo Liñán F. Domínguez Cunchillos A. Manuel Vázquez M. Fernández Venegas M.ª I. Manzano Martín SECCIÓN DE PATOLOGÍA DE LA MAMA Asociación Española de Cirujanos Y. A. Martínez Mateo R. Robles Fraguas D. Martínez Ramos L. Rodrigo Hernanz F. J. Medina Cano J. M. Rodríguez Alonso J. Medrano González F. X. Rodríguez Alsina J. M.ª Miguelena Bobadilla R. Rodríguez Fernández A. Moral Duarte I. Rodríguez Prieto C. Moreno Sanz A. Rodríguez Sánchez T. Muñoz Fernández C. A. Rodríguez Sánchez M.ª A. Nieto Gallo R. Rojo Blanco E. Olivo Valverde E. Salgado Pascual R. Orellana García F. Sánchez de Pedro M. Oset García S. Sánchez-Molero Pérez S. Ortega Ruiz M.ª A. Santana Borbones J. Petrement Briones M. Á. Sanz de Pablo M.ª E. Pertejo Muñoz A. Sierra García R. Pardo García L. Simón Monterde L. Pina Insausti V. Soria Aledo R. de la Plaza Llamas J. M.ª Sousa Vaquero R. M.ª Quintana de la Cruz G. Tadeo Ruiz J. M. Ramia Ángel R. Tobalina Bonis D. Ramírez Soler N. Torres Waldhaus L. Rabadán Ruiz J. A. Torró Richart M. Ramos Boyero J. M. del Val Gil T. Ramos Grande V. Vega Benítez M. Ribeiro González E. Veloso Veloso F. Ripoll Orts F. Vicente García A. Riquelme Oliveira V. Vigorita S. Rivas Fidalgo F. Villalba Ferrer J. Rivero Déniz L. Zubiaga Toro Presentación Han pasado ya diez años desde la presentación de la primera edición de la Guía de Cirugía de la Mama de la Asociación Española de Cirujanos (AEC). Los avan- ces de la medicina, especialmente en el campo de la oncología y en el manejo multidisciplinar de la patología mamaria, hacen necesarias nuevas actualizaciones de conocimientos, por lo que considerábamos que este tiempo era un periodo más que suficiente para proceder a una actualización de la guía clínica mediante la elaboración de una segunda edición. En la Sección de Patología de la Mama de la AEC se asumió el reto con ilusión y cariño para que hoy, esta segunda edición de la Guía ya sea una realidad. Desde la Junta Directiva de la Sección se distribuyó y se coordinó el trabajo de más de 110 cirujanos, miembros de la Sección y expertos en patología mamaria, que han participado como autores y coautores de los diferentes capítulos. Desde su creación, la Sección de Patología de la Mama está integrada por ciru- janos de todo el país que tenemos en común el interés por este campo de la cirugía y que en la actualidad trabajamos la mama dentro de los servicios de cirugía o incorporados a unidades multidisciplinares de patología mamaria. En los últimos años la Sección ha experimentado un crecimiento progresivo, lo cual es indicador de nuevas incorporaciones de cirujanos jóvenes que nos han ido estimulando para mantener un buen nivel de trabajo. A lo largo del tiempo, la Sección ha desarrollado y participado en múltiples ac- tividades: reuniones, congresos nacionales, cursos de formación en cirugía onco- plástica, cursos de formación para residentes y especialistas quirúrgicos, y, sobre todo, ha sido capaz de crear el clima para favorecer el aprendizaje y compartir experiencias entre nosotros mismos. La elaboración de una guía como esta no es más que el reflejo y la culminación de todos estos aspectos en un documento al que podamos recurrir para aprender y revisar los temas que necesitemos. Por último, y no menos importante, como editores, queremos resaltar nuestro agradecimiento a la Asociación Española de Cirujanos, a su Directiva y a su Co- mité Científico por el apoyo y las facilidades para que este proyecto haya podido desarrollarse. Fernando Domínguez Cunchillos Juan Blas Ballester Sapiña Gonzalo de Castro Parga Prólogo Hace diez años, en el prólogo de la primera Guía Clínica de Cirugía de la Mama de la Asociación Española de Cirugía (AEC), expresaba mi satisfacción por el honor recibido, que atribuía al reconocimiento de mi dedicación a la difu- sión del estudio interdisciplinario de la mama normal y patológica, defendiendo el papel importante de la Cirugía, que venía obligada a asumir la necesidad del trabajo conjunto con todas las especialidades relacionadas. En estos años, el interés creciente en la investigación del cáncer de mama, fun- damentado en la interdisciplinaridad de la Senología, que ya es universalmente aceptada, ha proporcionado grandes avances científicos que aportan nuevos conoci- mientos con repercusión en la clínica. Es imprescindible una puesta al día de la Guía Clínica para incorporar las aportaciones útiles y estar preparados para asumir tam- bién las que continuamente se van produciendo. Sin embargo, esto no es fácil, hay que separar lo sensacional de lo sensacionalista y dar información fundamentada y útil. Según el Institut of Medicine (IOM), una Guía debe contener un “Conjunto de recomendaciones desarrolladas de forma sistemática para ayudar a los profesionales en la toma de decisiones sobre la atención sanitaria más apropiada, seleccionando las opciones de diagnóstico y/o tratamiento más adecuados al abordaje de un pro- blema de salud o una condición clínica específica”. Esto no se resuelve con unos simples protocolos, ni es un proceso estático. Hay que profundizar y analizar las aportaciones para ofrecer al cirujano toda aquella información que sirva, además, para crear un criterio que se pueda ir actualizando y demostrar que la Cirugía sigue teniendo gran importancia y necesita adaptaciones para seguir integrada en el con- cepto de la Senología/Mastología, que, debe reconocerse, ha representado el funda- mento imprescindible para todas las mejoras alcanzadas en la práctica asistencial. Pienso que Fernando Domínguez, Blas Ballester y Gonzalo de Castro han com- prendido bien esta necesidad y nos presentan un trabajo que repasa ampliamente los múltiples aspectos precisos para que la Cirugía siga ocupando el papel que le corresponde en la solución de los problemas de las afecciones mamarias, funda- mentado en el estudio global e integrador de la mama normal y patológica. Por la selección de los temas y la forma de exponerlos, podría considerarse este libro, más que una simple guía, como un tratado de Patología Mamaria, pero ya hemos visto que, para que se cumpla la definición que de Guía hace el IOM, no basta con unos protocolos limitados a un área concreta. En el complejo estado de los conocimientos en este momento, creo imprescindible el esfuerzo que se ha hecho de ofrecer también la información teórica necesaria para que el lector interesado adquiera su propio criterio y esté en condiciones de irlo adaptando a los cambios que siguen produciéndose. Quiero insistir en la oportunidad de esta nueva edición y de su amplio formato, pues estamos en un momento de tal desarrollo de conocimientos –especialmente en relación con el cáncer de mama, pero sin olvidar la importancia epidemiológi- ca de la patología benigna, con aportaciones casi constantes de logros sensaciona- les (y, a veces, demasiado sensacionalistas)– que nos puede hacer creer que ya te- nemos la solución del problema, o al menos de una parte. Seamos conscientes de que, a lo largo de la historia, cada vez que ha aparecido una nueva teoría, un nuevo enfoque de tratamiento, una nueva técnica quirúrgica, nuevos fármacos, nuevas tecnologías, nuevas estrategias (que ahora llamamos cambios de paradigmas), por parte de nuestros antepasados y podría ser que en nosotros mismos, ha habido la sensación de poder tener dominado el cáncer.
Recommended publications
  • Breast-Reconstruction-For-Deformities
    ASPS Recommended Insurance Coverage Criteria for Third-Party Payers Breast Reconstruction for Deformities Unrelated to AMERICAN SOCIETY OF PLASTIC SURGEONS Cancer Treatment BACKGROUND Burn of breast: For women, the function of the breast, aside from the brief periods when it ■ Late effect of burns of other specified sites 906.8 serves for lactation, is an organ of female sexual identity. The female ■ Acquired absence of breast V45.71 breast is a major component of a woman’s self image and is important to her psychological sense of femininity and sexuality. Both men and women TREATMENT with abnormal breast structure(s) often suffer from a severe negative A variety of reconstruction techniques are available to accommodate a impact on their self esteem, which may adversely affect his or her well- wide range of breast defects. The technique(s) selected are dependent on being. the nature of the defect, the patient’s individual circumstances and the surgeon’s judgment. When developing the surgical plan, the surgeon must Breast deformities unrelated to cancer treatment occur in both men and correct underlying deficiencies as well as take into consideration the goal women and may present either bilaterally or unilaterally. These of achieving bilateral symmetry. Depending on the individual patient deformities result from congenital anomalies, trauma, disease, or mal- circumstances, surgery on the contralateral breast may be necessary to development. Because breast deformities often result in abnormally achieve symmetry. Surgical procedures on the opposite breast may asymmetrical breasts, surgery of the contralateral breast, as well as the include reduction mammaplasty and mastopexy with or without affected breast, may be required to achieve symmetry.
    [Show full text]
  • Congenital Problems in the Pediatric Breast Disclosure
    3/20/2019 Congenital Problems in the Pediatric Breast Alison Kaye, MD, FACS, FAAP Associate Professor Pediatric Plastic Surgery Children’s Mercy Kansas City © The Children's Mercy Hospital 2017 1 Disclosure • I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME activity • I do not intend to discuss an unapproved/investigative use of a commercial product/device in my presentation 1 3/20/2019 Pediatric Breast • Embryology • Post-natal development • Hyperplasia • Hypoplasia • Deformation Embryology 4th week of gestation: 2 ridges of thickened ectoderm appear on the ventral surface of the embryo between the limb buds 2 3/20/2019 Embryology By the 6th week ridges disappear except at the level of the 4th intercostal space Breast Embryology In other species multiple paired mammary glands develop along the ridges – Varies greatly among mammalian species – Related to the number of offspring in each litter 3 3/20/2019 Neonatal Breast • Unilateral or bilateral breast enlargement seen in up to 70% of neonates – Temporary hypertrophy of ductal system • Circulating maternal hormones • Spontaneous regression within several weeks Neonatal Breast • Secretion of “witches’ milk” – Cloudy fluid similar to colostrum – Water, fat, and cellular debris • Massaging breast can exacerbate problem – Persistent breast enlargement – Mastitis – Abscess 4 3/20/2019 Thelarche • First stage of normal secondary breast development – Average age of 11 years (range 8-15 years) • Estradiol causes ductal and stromal tissue growth • Progesterone causes alveolar budding and lobular growth Pediatric Breast Anomalies Hyperplastic Deformational Hypoplastic 5 3/20/2019 Pediatric Breast Anomalies Hyperplastic Deformational Hypoplastic Polythelia Thoracostomy Athelia Polymastia Thoracotomy Amazia Hyperplasia Tumor Amastia Excision Thermal Tumors Poland Injury Syndrome Tuberous Gynecomastia Penetrating Injury Deformity Adapted from Sadove and van Aalst.
    [Show full text]
  • Análise De Receptores Hormonais De Estrógeno E Progesterona Em
    NUBERTO HOPFGARTNER TEIXEIRA Análise de receptores hormonais de estrógeno e progesterona em hipertrofia mamária versus normomastia, avaliação de presença e densidade com uma nova proposta de classificação das hipertrofias mamárias Tese apresentada à Faculdade de Medicina da Universidade de São Paulo para obtenção do Título de Doutor em Ciências Programa de Clínica Cirúrgica Orientador: Prof. Dr. Marcio Paulino Costa São Paulo 2019 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. Dedico esta tese A minha esposa Vivian. Ao meu filho Henri. Ao meu falecido pai que me modelou para vida. À minha mãe que sempre se mostrou uma batalhadora. AGRADECIMENTOS Agradeço ao meu orientador Prof. Dr. Marcio Paulino Costa e ao Departamento de Patologia nas pessoas dos patologistas: Evelin Sanchez, Profa. Dra. Sheila Siqueira e Prof. Dr. Venâncio Avancini Ferreira Alves, os quais possibilitaram esta tese e cujas análises me permitiram concluir. Aos pacientes que concederam suas mamas para participação deste estudo. Ao Prof. Dr. Rolf Gemperli, Professor Titular da Disciplina de Cirurgia Plástica. “A tarefa não é tanto ver aquilo que ninguém viu, mas pensar o que ninguém ainda pensou sobre aquilo que todo mundo vê”. Arthur Schopenhauer NORMALIZAÇÃO ADOTADA Esta tese está de acordo com as seguintes normas, em vigor no momento desta publicação: Referências: adaptado de International Committee of Medical Journals Editors (Vancouver). Universidade de São Paulo. Faculdade de Medicina. Divisão de Biblioteca e Documentação. Guia de apresentação de dissertações, teses e monografias. Elaborado por Anneliese Carneiro da Cunha, Maria Julia de A.
    [Show full text]
  • Clinical and Imaging Evaluation of Nipple Discharge
    REVIEW ARTICLE Evaluation of Nipple Discharge Clinical and Imaging Evaluation of Nipple Discharge Yi-Hong Chou, Chui-Mei Tiu*, Chii-Ming Chen1 Nipple discharge, the spontaneous release of fluid from the nipple, is a common presenting finding that may be caused by an underlying intraductal or juxtaductal pathology, hormonal imbalance, or a physiologic event. Spontaneous nipple discharge must be regarded as abnormal, although the cause is usually benign in most cases. Clinical evaluation based on careful history taking and physical examination, and observation of the macroscopic appearance of the discharge can help to determine if the discharge is physiologic or pathologic. Pathologic discharge can frequently be uni-orificial, localized to a single duct and to a unilateral breast. Careful assessment of the discharge is mandatory, including testing for occult blood and cytologic study for malignant cells. If the discharge is physiologic, reassurance of its benign nature should be given. When a pathologic discharge is suspected, the main goal is to exclude the possibility of carcinoma, which accounts for only a small proportion of cases with nipple discharge. If the woman has unilateral nipple discharge, ultrasound and mammography are frequently the first investigative steps. Cytology of the discharge is routine. Ultrasound is particularly useful for localizing the dilated duct, the possible intraductal or juxtaductal pathology, and for guidance of aspiration, biopsy, or preoperative wire localization. Galactography and magnetic resonance imaging can be selectively used in patients with problematic ultrasound and mammography results. Whenever there is an imaging-detected nodule or focal pathology in the duct or breast stroma, needle aspiration cytology, core needle biopsy, or excisional biopsy should be performed for diagnosis.
    [Show full text]
  • NDA/BLA Multi-Disciplinary Review and Evaluation
    NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) NDA/BLA Multi-Disciplinary Review and Evaluation Application Type NDA Application Number(s) NDA 214154 (IND 110682) Priority or Standard Standard Submit Date(s) April 15, 2020 Received Date(s) April 15, 2020 PDUFA Goal Date April 15, 2021 Division/Office Division of Urology, Obstetrics, and Gynecology (DUOG) / Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM) Review Completion Date April 15, 2021 Established/Proper Name drospirenone and estetrol tablets (Proposed) Trade Name Nextstellis Pharmacologic Class Combination hormonal contraceptive Applicant Mayne Pharma LLC Dosage form Tablet Applicant proposed Dosing x Take one tablet by mouth at the same time every day. Regimen x Take tablets in the order directed on the blister pack. Applicant Proposed For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy Recommendation on Approval Regulatory Action Recommended For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy (if applicable) Recommended Dosing x Take one pink tablet (drospirenone 3 mg, estetrol Regimen anhydrous 14.2 mg) by mouth at the same time every day for 24 days x Take one white inert tablet (placebo) by mouth at the same time every day for 4 days following the pink tablets x Take tablets in the order directed on the blister pack 1 Reference ID: 4778993 NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) Table of Contents Table of Tables .................................................................................................................... 5 Table of Figures ................................................................................................................... 7 Reviewers of Multi-Disciplinary Review and Evaluation ...................................................
    [Show full text]
  • Low Risk of Skin and Nipple Sensitivity and Lactation Issues
    Breast Surgery Aesthetic Surgery Journal 2016, Vol 36(6) 672–680 Low Risk of Skin and Nipple Sensitivity and © 2016 The American Society for Aesthetic Plastic Surgery, Inc. This is an Open Access article Lactation Issues After Primary Breast distributed under the terms of the Creative Commons Attribution- Augmentation with Form-Stable Silicone NonCommercial-NoDerivs licence (http://creativecommons.org/ Implants: Follow-Up in 4927 Subjects licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that Herluf G. Lund, MD, FACS; Janet Turkle, MD; Mark L. Jewell, MD; the work is properly cited. For commercial re-use, please contact and Diane K. Murphy, MBA [email protected]. DOI: 10.1093/asj/sjv266 Downloaded from www.aestheticsurgeryjournal.com Abstract http://asj.oxfordjournals.org/ Background: Natrelle 410 implants (Allergan, Inc., Irvine, CA) are approved in the United States for breast augmentation, reconstruction, and revision. Objectives: To assess the risk of nipple and skin sensation changes and lactation issues in subjects receiving implants for primary breast augmentation and ascertain whether differences based on incision site exist. Methods: We used 410 Continued Access study data to assess safety and effectiveness of devices implanted via inframammary or periareolar incision sites. Subjects were evaluated preoperatively and at 4 weeks, 6 months, and annually up to 10 years postoperatively. Lactation issues and nipple and skin sensation changes (hypersensitivity/paresthesia, loss of sensation) were assessed. Results: The inframammary and periareolar cohorts comprised 9217 and 610 implanted devices, with mean follow-up of 4.1 years (range, 0-10.1 years) and 4.8 years (range, 0-10.1 years), respectively.
    [Show full text]
  • Delguercio Day Proceedings 2018
    Fifteenth Annual Louis R.M. Del Guercio Distinguished Visiting Professorship and Research Day Presented at New York Medical College 7 Dana Road Facility Valhalla, New York December 19, 2018 PROCEEDINGS Program Committee: JORGE CON, MD THOMAS DIFLO, MD RIFAT LATIFI, MD KRIST NIKOLLA, MPH JOHN A. SAVINO, MD KATHRYN SPANKNEBEL, MD THOMAS SULLIVAN KEVIN WOLFE, PHD 1 Table of Contents: Podium Presentations…...............................p.03 Moderated Oral Poster Presentations…......p.29 Poster Exhibits…….…................................p.59 2 Podium Presentations (In alphabetical order) 3 TITLE: PREOPERATIVE MENINGIOMA EMBOLIZATION IS SAFE BUT COSTS MORE THAN NON- EMBOLIZATION RESECTIONS: A MULTI-CENTER RETROSPECTIVE MATCHED CASE-CONTROL STUDY Authors: ANUBHAV G. AMIN MD1(PGY6), John V. Wainwright MD1 , Ilya Rybkin MS2, Hussam Abou Al- Shaar MD3, William T. Couldwell MD/PhD4, Fawaz Al-Mulfti MD1, Justin Santarelli MD1, Chirag D. Gandhi MD1, Meic H. Schmidt MD1, Christian Bowers MD1 1 Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 2 New York Medical College, Valhalla, NY 3 Department of Neurosurgery, Hofstra/Northwell, Manhasset, NY 4 Department of Neurosurgery, University of Utah, Salt Lake City, UT Background: The literature has been mixed regarding the potential benefit of reduced blood loss with preoperative meningioma embolization (ME). However, a comparison of embolization-associated costs with non-embolization meningioma (NE) patients has not been completed. Objective: To determine the potential benefits of ME in blood loss and its associated costs. Design/Methods: This is a retrospective case control study matched for tumor location, size, and radiographic appearance between two centers. We reviewed demographic and clinical data for 29 matched meningioma patients from each center.
    [Show full text]
  • International Journal of Current Advan Urnal of Current Advanced Research
    International Journal of Current Advanced Research ISSN: O: 2319-6475, ISSN: P: 2319 – 6505, Impact Factor: SJIF: 5.995 Available Online at www.journalijcar.org Volume 6; Issue 3; March 2017; Page No. 2496-2499 DOI: http://dx.doi.org/10.24327/ijcar.2017.2499.0036 CASE REPORT CRYSTALLIZING GALACTOCELE - HISTOPATHOLOGICAL DIAGNOSIS OF AN ENIGMATIC ENTITY Radhika Yajaman Gurumurthy* and Nadig Siddharth Shankar Consultant Pathologists, Bhagavan Pathology Laboratory, #1116, 5th Cross, 1503, Srirampet, Vinoba Road, Mysore - 570001 ARTICLE INFO ABSTRACT Article History: Galactocele is a benign cystic lesion occurring most commonly during pregnancy and lactational period. Sometimes the inspissated secretions within the galactocele undergo Received 8th December, 2016 th precipitation forming crystals. It is very essential to differentiate this condition from Received in revised form 19 January, 2017 various benign and malignant conditions forming crystals. In this case report we describe Accepted 12th February, 2017 th the cytological and histopathological features of a very rare entity known as crystallizing Published online 28 March, 2017 galactocele. To the best of our knowledge this is the sixth reported case in English literature. Key words: Crystallizing Galactocele, Galactocele, Benign Breast Diseases. Copyright©2017 Radhika Yajaman Gurumurthy and Nadig Siddharth Shankar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
    [Show full text]
  • Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal
    National Education Curriculum Specialty Curricula Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Table of Contents Section I: Biliary ........................................................................................................................................................ 3 Section II: Liver ....................................................................................................................................................... 19 Section III: Pancreas ............................................................................................................................................... 35 Section IV: Renal and Lower Urinary Tract ........................................................................................................ 43 Section V: Spleen ..................................................................................................................................................... 67 Section VI: Adrenal ................................................................................................................................................. 75 Section VII: Abdominal Vasculature ..................................................................................................................... 81 Section VIII: Gastrointestinal Tract (GI) .............................................................................................................. 91
    [Show full text]
  • ISAPS Global Survey Results 2018
    ISAPS INTERNATIONAL SURVEY ON AESTHETIC/COSMETIC PROCEDURES performed in 2018 CONTENTS About ISAPS ..................................................................................................................page 3 Surgical Totals Ranked by Category ...............................................................page 29 About the International Survey on Nonsurgical Totals Ranked by Category .......................................................page 30 Aesthetic/Cosmetic Procedures ..........................................................................page 4 Countries Ranked by Total Number of Procedures ................................page 31 Countries Ranked by Estimated HIGHLIGHTS OF THE 2018 STATISTICS Number of Plastic Surgeons .............................................................................page 32 2018 Statistics at a Glance .......................................................................................pages 6-7 Surgical Procedure Group Ranking by Country ........................................page 33 Nonsurgical Procedure Group Ranking by Country ................................page 34 NUMBER OF WORLDWIDE PROCEDURES PROCEDURES PERFORMED BY PLASTIC SURGEONS Number of Worldwide Surgical Procedures ...............................................page 9 Number of Worldwide Surgical Procedures Number of Worldwide Nonsurgical Procedures .........................................page 10 Performed by Plastic Surgeons ........................................................................page 36 Surgical Procedures
    [Show full text]
  • Breast Disorders in Girls and Adolescents. Is There a Need for a Specialized Service?
    Original Study Breast Disorders in Girls and Adolescents. Is There a Need for a Specialized Service? Lina Michala MRCOG, PhD *, Alexandra Tsigginou MD, PhD, Dimitris Zacharakis MD, Constantine Dimitrakakis MD, PhD 1stDepartment of Obstetrics and Gynaecology, University of Athens, Alexandra Hospital, Athens, Greece abstract Introduction: Minor breast concerns in childhood and adolescence are common and lead to increased anxiety among young patients and their families, particularly due to high correlation with breast cancer. However, most breast services aim at managing adults and triaging patients with breast cancer, whereas adolescent medicine specialists or pediatricians are usually not appropriately trained to identify and treat breast pathology. Methods: We reviewed hospital records of all patients attending a pediatric and adolescent gynecology or breast clinic of a tertiary referral hospital, with a breast related symptom, between January 2009 and December 2011. We collected information regarding age at presen- tation, age at menarche, diagnosis, management and outcome. Results: We identified 81 patients of which 11 presented with an abnormal nipple or areolar secretion, 33 had a palpable lump, 20 had mastitis, and 16 had unequal breast development. One patient presented with virginal breast hypertrophy. Three out of 11 of the patients with an abnormal secretion had a cyst identified on ultrasonography. Out of the palpable lumps 12 were fibroadenomas, 3 were phyllodes tumors, and 14 were cystic in nature. The phyllodes tumors and half of the fibroadenomas were removed. The remaining fibroadenomas remain under regular ultrasonographic follow-up. All cases of mastitis were treated conservatively and resolved with broad spectrum antibiotic treatment. Conclusion: In our series, no malignancies were identified.
    [Show full text]
  • Incidence of Breast and Nipple Abnormalities Among Primigravid Women in Sri Lanka
    Original Articles Incidence of breast and nipple abnormalities among primigravid women in Sri Lanka Sujeewa Amarasena 1 Sri Lanka Journal of Child Health , 2006; 35 : 51-4 (Key words: incidence, breast and nipple abnormalities, primigravid women, Sri Lanka) Abstract breast 4, unilateral or bilateral absence of breast Objective To determine the incidence of breast and (amastia) and tubular breast deformity 1. These are nipple abnormalities among primigravid women and well-recognized causes of lactation failure. Some their effects on lactation in Sri Lanka. abnormalities are correctable with antenatal interventions. One study identified the incidence of Design Prospective descriptive survey. inverted or nonprotractile nipples resulting in attachment difficulties to be 10% among 1926 Method All primigravid women attending antenatal nulliparous women 5. Incidence of these abnormalities clinics of the university obstetric unit, giving and their correctability among Sri Lankan women is informed consent, were recruited into the study. Their not known. breasts were examined clinically and breast abnormalities noted. They were followed up until Objectives successful lactation was established. 1. To assess the incidence of breast and nipple Results 956 mothers were examined. 768 had normal abnormalities among primigravid women breasts and 188 abnormalities were noted. 725 attending antenatal clinics in Sri Lanka. completed the study. 72.5% established successful lactation. 80 had flat nipples of whom 52 completed 2. To assess the correctability of flat or inverted the study. 44 flat nipples were corrected antenatally nipples with Hoffman 4 exercises. with exercises. All established lactation successfully. Other abnormalities included breast surgery, 3. To assess the effects of antenatal interventions hypoplastic breasts or breast asymmetry.
    [Show full text]